Learn more

LILLY CO ELI

Overview
  • Total Patents
    45,651
  • GoodIP Patent Rank
    393
  • Filing trend
    ⇩ 20.0%
About

LILLY CO ELI has a total of 45,651 patent applications. It decreased the IP activity by 20.0%. Its first patent ever was published in 1903. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SQUIBB BRISTOL MYERS CO, TROPONWERKE GMBH & CO KG and PHARMACIA SPA.

Patent filings in countries

World map showing LILLY CO ELIs patent filings in countries
# Country Total Patents
#1 United States 5,244
#2 EPO (European Patent Office) 3,088
#3 Canada 3,043
#4 Australia 2,679
#5 Israel 2,014
#6 WIPO (World Intellectual Property Organization) 1,886
#7 Japan 1,643
#8 South Africa 1,430
#9 Hungary 1,223
#10 China 1,183
#11 United Kingdom 1,154
#12 Brazil 1,127
#13 Ireland 969
#14 New Zealand 932
#15 Republic of Korea 918
#16 Denmark 832
#17 Argentina 816
#18 Mexico 756
#19 Spain 709
#20 France 645
#21 Norway 644
#22 Switzerland 607
#23 Philippines 555
#24 Germany 554
#25 Taiwan 547
#26 Poland 534
#27 Finland 473
#28 Austria 430
#29 Czechia 421
#30 Portugal 399
#31 Romania 397
#32 Greece 396
#33 Yugoslavia (Serbia and Montenegro) 381
#34 Peru 374
#35 Belgium 363
#36 EAPO (Eurasian Patent Organization) 361
#37 Netherlands 356
#38 USSR (Union of Socialist Soviet Republics) 351
#39 Czechoslovakia 342
#40 Sweden 338
#41 Hong Kong 303
#42 Colombia 277
#43 Ukraine 256
#44 German Democratic Republic 253
#45 Russian Federation 219
#46 Bulgaria 213
#47 Singapore 212
#48 Malaysia 206
#49 Italy 205
#50 Ecuador 176
#51 Costa Rica 168
#52 Egypt 156
#53 Dominican Republic 152
#54 Chile 146
#55 Morocco 139
#56 Serbia 132
#57 Tunisia 122
#58 Luxembourg 109
#59 El Salvador 108
#60 Cyprus 105
#61 Jordan 98
#62 Croatia 90
#63 Indonesia 82
#64 India 78
#65 African Regional Industrial Property Organization 68
#66 Slovakia 66
#67 African Intellectual Property Organization 65
#68 Montenegro 57
#69 Turkey 50
#70 Algeria 30
#71 Slovenia 26
#72 Honduras 24
#73 Guatemala 22
#74 Malawi 21
#75 Zambia 20
#76 Kenya 14
#77 Latvia 13
#78 Zimbabwe 12
#79 Lithuania 9
#80 Panama 9
#81 Georgia 8
#82 Estonia 7
#83 Iceland 4
#84 Republic of Moldova 2
#85 Tajikistan 2
#86 Uruguay 2
#87 Saudi Arabia 1

Patent filings per year

Chart showing LILLY CO ELIs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Cullinan George Joseph 437
#2 Schaus John Mehnert 387
#3 Sawyer Jason Scott 341
#4 Hipskind Philip Arthur 341
#5 Sall Daniel Jon 320
#6 Dodge Jeffrey Alan 308
#7 Jones Charles David 303
#8 Bryant Henry Uhlman 292
#9 Hamill Robert L 275
#10 Coates David Andrew 261

Latest patents

Publication Filing date Title
WO2021076620A1 Recombinantly engineered, lipase/esterase-deficient mammalian cell lines
WO2021050380A1 Medication delivery device with needle carrier
WO2021050384A1 Medication delivery device with needle carrier
WO2021046072A1 Proteins comprising t-cell receptor constant domains
WO2021041378A1 Methods and apparatus for determining device dosage
WO2021041319A1 Crystalline forms of a cd73 inhibitor
WO2021041184A1 Rotary plunger pump subsystems
WO2021034902A2 Methods and apparatus for aspects of a dose detection system
WO2021034815A1 Methods of making incretin analogs
WO2021026059A1 7,8-DIHYDRO-4H-PYRAZOLO[4,3-c]AZEPINE-6-ONE COMPOUNDS
WO2021025975A1 Pyrimidine-5-carboxamide compound
WO2021022149A1 Insulin analogs and methods of using the same
WO2021021877A1 Gipr-agonist compounds
WO2021007394A1 Systems and methods for detecting cognitive decline with mobile devices
WO2021007155A1 Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate, and preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide acetate
US2020407347A1 Glucagon-like peptide1 receptor agonists
WO2020263706A1 Systems and methods for detecting missed bolus doses
US2020392118A1 Disubstituted pyrazole compounds
WO2020257043A1 Processes and intermediates for the preparation of 2-(2,6-dichlorophenyl)-1-[(1s,3r)-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-3,4-dihydroisoquinolin-2(1h)-yl]ethenone
WO2020247429A1 Pyrrolidine compounds